Peptide guide
DSIP Peptide and Sleep: What the Evidence Actually Shows
DSIP peptide sleep claims sit on decades of mixed human data. Klarovel reviews the mechanism, dose ranges, regulatory status, and protocol guardrails.
June 8, 2026·11 min read
Evidence-based peptide writing
Research-backed articles on peptides, protocols, and longevity science.
Every post on this blog is built around a single rule: the load-bearing claim has to point at a peer-reviewed source. The catalog spans five clusters: the GH-axis (CJC-1295, ipamorelin, tesamorelin, MK-677), the GLP-1 class (semaglutide, tirzepatide, retatrutide, cagrilintide), tissue healing (BPC-157, TB-500, GHK-Cu, KPV), cognitive peptides (semax, selank, dihexa), and longevity (NAD+, epitalon, DSIP, thymosin alpha-1). Pieces are reviewed against PubMed, ClinicalTrials.gov, FDA, EMA, Helsedirektoratet, FHI, and Legemiddelverket. We hedge claims the literature hedges and we name the gaps where the human-trial database is still light.
Explore by cluster
Growth-hormone axis
GHRH analogues and GH-releasing peptides for body composition, recovery, and the IGF-1 lever. CJC-1295, ipamorelin, tesamorelin, sermorelin, MK-677, GHRP-2 and GHRP-6.
GLP-1 class + metabolic
Incretin-receptor agonists for weight management and metabolic disease. Semaglutide, tirzepatide, retatrutide, cagrilintide, liraglutide. Class explainers, head-to-head comparisons, and the Norwegian regulatory picture.
Tissue healing + recovery
Peptides studied for tissue repair, gut barrier, and inflammation. BPC-157, TB-500, GHK-Cu, KPV, and the stacking question the research community keeps returning to.
Cognitive peptides
Compounds with evidence for attention, mood, and neuroplasticity. Semax, selank, dihexa, cerebrolysin. Includes the where-the-data-runs-out caveats.
Longevity + metabolic
Compounds in the longevity and metabolic-health corner of the catalog. NAD+, epitalon, DSIP, thymosin alpha-1, plus the regulatory framing each one currently sits in.
Each guide opens with a Key Takeaways box that summarises the load-bearing claims in 3 to 5 bullets. The body always moves mechanism, evidence, dosing, then risk profile. Reviewer date and credentials sit in the byline of every post. If you are new to peptide research, the [What are peptides used for](/blog/what-are-peptides-used-for) and [What is peptide therapy](/blog/what-is-peptide-therapy) posts are the right starting points before the deeper protocol guides.
Safety
Are Peptides Legal in the US? FDA & DEA Status in 2026
The legal status of peptides in the US is layered, fast-moving, and easy to misread. Here is what FDA, DEA, and the 503A/503B framework actually say in 2026.
June 6, 2026·12 min read
Comparison
CJC-1295 vs Sermorelin: GHRH Head-to-Head (2026)
CJC-1295 vs sermorelin compared on half-life, dosing cadence, published human data, and side-effect profile. Daily vs weekly, with citations.
June 6, 2026·10 min read
Comparison
BPC-157 vs KPV: gut-healing peptide head-to-head (2026)
BPC-157 vs KPV compared on mechanism, oral stability, colitis evidence, and side effects. The deciding factor: where in the gut the inflammation actually sits.
June 4, 2026·13 min read
Science
Peptides for ADHD: What Semax Research Actually Shows
Honest look at peptides and ADHD focus. Semax, Selank, BDNF mechanisms, and what the preclinical and pilot data actually support in 2026.
June 3, 2026·11 min read
Comparison
AOD-9604 vs Tirzepatide: Targeted vs Systemic (2026)
AOD-9604 vs tirzepatide compared head-to-head: mechanism, dose ranges, side-effect ledger, and which the published trials actually back for fat loss.
June 2, 2026·13 min read
Peptide guide
SS-31 Peptide: The Mitochondrial Longevity Angle Explained
SS-31 (elamipretide) targets cardiolipin to restore mitochondrial function. What the FDA approval, clinical trials, and aging research actually show.
June 1, 2026·12 min read
Comparison
Ipamorelin vs Sermorelin: GH Axis Head-to-Head (2026)
Ipamorelin vs sermorelin compared on mechanism, dosing, evidence, and side effects. Which GH-axis peptide actually fits your goal? Sourced from primary trials.
May 30, 2026·12 min read
Safety
Peptides on the Doping List: A 2026 WADA Reference
What every Norwegian competitive athlete should know about peptides on the WADA 2026 prohibited list, S0/S2/S4 classifications, and detection windows.
May 29, 2026·13 min read
Comparison
Cagrilintide vs Tirzepatide: Amylin or Dual Incretin?
Cagrilintide targets amylin satiety; tirzepatide hits GIP + GLP-1. A head-to-head on dosing, weight loss, side effects, and which mechanism fits which goal.
May 28, 2026·10 min read
Comparison
SARMs vs Peptides: How the Two Compound Classes Actually Differ
SARMs hit androgen receptors and carry liver and cardiovascular risk; peptides act as targeted signaling molecules. A clinical-grade comparison.
May 28, 2026·10 min read
Safety
Are Peptides Safe? The Honest 2026 Safety Guide
Are peptides safe? An honest 2026 look at side effects, who should avoid them, sourcing risk, and the legal picture in Norway.
May 26, 2026·11 min read
Comparison
GLP-1 Weight Loss Medications Compared: 2026 Guide
Tirzepatide, semaglutide, liraglutide and the GLP-1 frontier compared by 2026 trial data: efficacy, side effects, dosing, and the Norway picture.
May 26, 2026·12 min read
Comparison
Peptides vs TRT: GH Secretagogues or Testosterone in 2026
Peptides vs TRT compared head-to-head: mechanism, dosing, side-effect profiles, and a decision rule for choosing between GH stacks and testosterone.
May 26, 2026·11 min read
Peptide guide
Peptides for Depression: Selank, Semax & the BDNF Case
An evidence-based look at peptides studied for depressive symptoms, focusing on Semax and Selank, their BDNF effects, dosing context, and what the science does not yet support.
May 25, 2026·10 min read
Safety
Peptide Side Effects: A Comprehensive Safety Guide 2026
Side effects across BPC-157, semaglutide, tirzepatide, melanotan II, ipamorelin and more. Trial-level adverse event data, monitoring rules, when to stop.
May 24, 2026·11 min read
Comparison
Cagrilintide vs Semaglutide: Two Pathways, One Decision (2026)
Cagrilintide is an amylin analogue. Semaglutide is a GLP-1 agonist. The REDEFINE trials show the deciding factor is whether you stack them or pick one.
May 23, 2026·11 min read
Peptide guide
Peptides for Sleep: DSIP, Selank and Epitalon Compared
How DSIP, Selank and Epitalon target different sleep failures (architecture, anxious wake-ups, melatonin decline) and what the research actually shows.
May 23, 2026·11 min read
Protocol
Peptide Injection Sites: A Site-by-Site Protocol Guide
A site-by-site review of abdomen, thigh, upper arm, and shoulder for peptide injections, with pharmacokinetic differences and rotation rules that protect tissue.
May 22, 2026·12 min read
Safety
GHK-Cu Legal Status in Norway: What Researchers Need to Know
GHK-Cu sits between cosmetic ingredient and prescription peptide in Norway. Here is what DMP, customs, and the EU cosmetics framework actually permit in 2026.
May 21, 2026·11 min read
Comparison
Peptides vs HGH: Is This Just Expensive Growth Hormone? (2026)
Peptides vs HGH compared on mechanism, dosing, side effects, and US legal status. The deciding factor is not strength, it is regulatory exposure.
May 21, 2026·14 min read
Peptide guide
Thymosin Alpha-1: Complete Guide to the Immune Peptide
Thymosin alpha-1 explained: mechanism, the hepatitis B reference dose, sepsis and COVID-19 trial data, safety profile, and what the research actually shows.
May 20, 2026·10 min read
Comparison
BPC-157 vs GHK-Cu: which tissue-repair peptide wins in 2026?
BPC-157 vs GHK-Cu compared on mechanism, dosing, evidence and side-effect profile. The deciding factor is which tissue you are actually trying to repair.
May 19, 2026·10 min read
Peptide guide
PT-141 Guide: Mechanism, Evidence, and Honest Limits
PT-141 (bremelanotide) acts on brain melanocortin receptors, not blood vessels. What the FDA approval, RECONNECT trials, and side-effect data actually show.
May 19, 2026·11 min read
Comparison
AOD-9604 vs semaglutide: lipolysis vs satiety (2026)
AOD-9604 vs semaglutide head-to-head: GH-fragment lipolysis against GLP-1 satiety. Trial data, dosing, side effects, and a clear decision rule.
May 18, 2026·11 min read
Science
GLP-1 Muscle Loss: What the Data Actually Shows in 2026
GLP-1 muscle loss is real but manageable. Trial data, mechanisms, and a protein-plus-resistance protocol to preserve lean mass during semaglutide or tirzepatide.
May 18, 2026·12 min read
Protocol
Peptide Injection Technique: A Research Skills Primer
How to think about peptide injection technique: site selection, angle, needle gauge, rotation, and sterility. A research-grade primer for protocol literacy.
May 18, 2026·10 min read
Comparison
Weight-Loss Medication in Norway 2026: The Complete Map
Every approved obesity medicine in Norway in 2026, plus the research-only frontier. Wegovy, Mounjaro, Saxenda, Ozempic, Mysimba, retatrutide.
May 18, 2026·14 min read
Comparison
Liraglutide vs semaglutide: which GLP-1 wins?
Head-to-head on Saxenda vs Wegovy: dosing, weight loss, cardiovascular data, and tolerability. STEP 8 and SELECT settle most of the argument.
May 16, 2026·11 min read
Comparison
Ozempic vs Wegovy: What Actually Separates Them
Same molecule, different label. A clinical breakdown of Ozempic and Wegovy: dose ceilings, approved uses, Norwegian reimbursement reality, and trial data.
May 16, 2026·12 min read
Comparison
CagriSema vs Semaglutide: Inside Novo Nordisk's Combo Bet
CagriSema pairs semaglutide with cagrilintide and hit 22.7% weight loss in REDEFINE 1. Here is what the phase 3 data actually shows, side by side.
May 15, 2026·12 min read
Comparison
Ipamorelin vs MK-677: Pulsatile or Sustained GH (2026)
Injectable ipamorelin vs oral MK-677: pulsatile pulses versus 24-hour elevation. Half-lives, dosing, side effects, and a clear decision rule.
May 14, 2026·11 min read
Peptide guide
Wegovy in Norway: A Complete Guide to Semaglutide 2.4 mg
Wegovy dosing, side effects, pricing in Norway, and STEP/SELECT trial outcomes for semaglutide 2.4 mg. A research-grade guide for adults considering treatment.
May 14, 2026·13 min read
Safety
Melanotan 2 in Norway: Law, Risks, and Safer Tan Options
What research shows about Melanotan 2, why DMP has not approved it in Norway, the documented melanoma case reports, and evidence-based alternatives for pigmentation goals.
May 13, 2026·12 min read
Science
The GH peptide axis: how GHRH, ghrelin, and IGF-1 connect
A pillar guide to the GH peptide axis: how GHRH analogs and ghrelin mimetics drive pulsatile growth hormone, and what somatopause changes.
May 12, 2026·11 min read
Peptide guide
Cagrilintide Complete Guide: Amylin Analog for Weight Loss
Cagrilintide is the long-acting amylin analog behind CagriSema. Mechanism, REDEFINE 1 data, dosing, side effects, and comparison to semaglutide, in plain English.
May 11, 2026·13 min read
Comparison
Ipamorelin vs CJC-1295: GHRP vs GHRH Head-to-Head (2026)
Ipamorelin vs CJC-1295 settled: one is a ghrelin-receptor pulse, the other a GHRH analog with a six-day half-life. Here is which to pick, and when.
May 11, 2026·12 min read
Peptide guide
What Are Peptides Used For? An Evidence-Based Primer
A clear, research-grounded look at what peptides are used for in 2026: from approved indications like diabetes and obesity to recovery research.
May 10, 2026·11 min read
Peptide guide
Peptides for Healing: Research-Backed Tissue Repair Guide
How peptides for healing actually work. Mechanisms, evidence, and protocol logic for BPC-157, TB-500, GHK-Cu, and KPV across tendon, skin, and gut.
May 9, 2026·13 min read
Peptide guide
AOD-9604 peptide: the fat-metabolism fragment guide
AOD-9604 is a 16-amino-acid growth hormone fragment studied for fat metabolism. What the trials actually showed, what they did not, and where it fits today.
May 8, 2026·12 min read
Protocol
How to inject peptides: technique, sites, rotation
How to inject peptides subcutaneously in 2026. Insulin syringe choice, four primary sites, rotation discipline, the 5-10 second hold, and the Norway frame.
May 7, 2026·17 min read
Science
What is peptide therapy? Three categories that matter
Peptide therapy means three different things in 2026: FDA-approved medicines, compounded peptides in a reopened grey zone, and research-only peptides.
May 5, 2026·18 min read
Peptide guide
KPV peptide guide: what the preclinical research shows
KPV is the three-amino-acid fragment of alpha-MSH. Preclinical data points to NF-kB suppression, gut and skin effects, but human trials remain absent.
April 28, 2026·15 min read
Peptide guide
Peptides for Muscle Growth: What the Data Says
Trials report 1.1 to 1.3 kg lean mass gain on growth-hormone peptides over 6 to 12 months. The data and what it does not show, plus WADA status.
April 28, 2026·15 min read
Peptide guide
Peptides for Weight Loss: What the 2026 Trial Data Says
Four peptide medications are FDA-approved for weight loss in 2026. Trial data, mechanism, side effects, and how the approved options compare.
April 28, 2026·17 min read
Peptide guide
Selank Peptide: Russian-Approved, Not FDA-Authorized
Selank peptide is a Russian-approved anxiolytic that modulates GABA-A and enkephalins. The mechanism, the 62-patient trial, and 2026 regulatory reality.
April 25, 2026·14 min read
Peptide guide
Semax Peptide: Approved in Russia, Unscheduled in the US
Semax peptide is a Russian-approved nootropic that raises BDNF and shows neuroprotective effects after stroke. The science and the 2026 regulatory reality.
April 25, 2026·14 min read
Safety
Are peptides legal in Norway? The 2026 regulatory answer
Peptides in Norway are mostly unlawful to import privately. What DMP stops at customs, what's approved, and how Norwegian law handles it.
April 24, 2026·15 min read
Peptide guide
Cognitive peptides: promise, evidence, and a retraction
Research-first walkthrough of cognitive peptides, what Semax, Selank, and DSIP actually do, which claims don't hold up, and what to watch in 2026.
April 22, 2026·22 min read
Protocol
Bacteriostatic water: why it matters and how much to use
Bacteriostatic water is the 0.9% benzyl-alcohol diluent that keeps reconstituted peptides stable for 28 days. Here's the chemistry, the volumes, and the math.
April 20, 2026·6 min read
Peptide guide
BPC-157: mechanism, evidence, and protocol guide
BPC-157 is the most-searched healing peptide. Here's the mechanism, the preclinical evidence, the limited human data, and how to think about the protocol.
April 20, 2026·9 min read
Protocol
BPC-157 + TB-500 stack: what the evidence actually says
The BPC-157 + TB-500 stack is the most common healing peptide protocol. Here's the mechanism rationale, the dosing framework, and what the evidence does, and doesn't, support.
April 20, 2026·10 min read
Comparison
BPC-157 vs TB-500: when to use each for tissue repair
BPC-157 and TB-500 are the two most-researched tissue-repair peptides. Different mechanisms, different use cases. Here's how to decide between them.
April 20, 2026·6 min read
Peptide guide
CJC-1295 + Ipamorelin: the GH stack mechanism explained
The CJC-1295 + Ipamorelin stack pairs a GHRH analogue with a GHRP for amplified growth hormone pulses. Here's the mechanism, the dose pattern, and what the research shows.
April 20, 2026·7 min read
Peptide guide
Epitalon: the longevity peptide explained
Epitalon is a tetrapeptide associated with telomerase activity and pineal-gland regulation. Here's what the research actually shows, and where the evidence is thin.
April 20, 2026·6 min read
Peptide guide
GHK-Cu copper peptide: skin and hair research review
GHK-Cu is the fastest-growing peptide in search volume. The copper complex is a legitimate biological signal, but the hype outruns the clinical data. Here's the real picture.
April 20, 2026·9 min read
Science
GLP-1 class: semaglutide, tirzepatide, retatrutide compared
Semaglutide, tirzepatide, and retatrutide share a pharmacology family but each activates different metabolic receptors. Here's what the difference actually means.
April 20, 2026·8 min read
Protocol
How to reconstitute peptides: a complete step-by-step guide
Peptide reconstitution is the step most people get wrong. Bacteriostatic water, sterile technique, dose math, storage, here's the evidence-based walkthrough.
April 20, 2026·9 min read
Peptide guide
Ipamorelin: the cleanest GHRP in the research catalogue
Ipamorelin is the most selective ghrelin mimetic in the GHRP class. No meaningful cortisol or prolactin elevation. Here's the mechanism, dose framework, and evidence.
April 20, 2026·6 min read
Peptide guide
MK-677 (ibutamoren): the oral GH secretagogue explained
MK-677 is the only orally active growth hormone secretagogue in the catalogue. Here's how the mechanism, the dosing pattern, and the side-effect trade-offs actually work.
April 20, 2026·6 min read
Peptide guide
NAD+ injections: mechanism, evidence, and dosing
NAD+ is the coenzyme powering cellular energy metabolism. Injection has become a longevity protocol anchor. Here's what the research actually shows about mechanism and dosing.
April 20, 2026·7 min read
Safety
Who shouldn't take peptides: contraindications guide
Peptides aren't for everyone. Active cancer, pregnancy, uncontrolled diabetes, severe kidney or liver impairment: what the evidence says about who should avoid which classes.
April 20, 2026·6 min read
Protocol
Peptide dosing math: mcg, mg, IU and syringe units
Peptide dose math is simple once you separate the three unit systems. Here's how mcg, mg, and IU relate, and how to read them off an insulin syringe.
April 20, 2026·7 min read
Peptide guide
Retatrutide: What the triple-agonist trials actually show
Retatrutide is the first triple GIP-GLP-1-glucagon agonist. Phase 3 trials show 28.7% weight loss at 68 weeks. Here's what the evidence actually shows.
April 20, 2026·11 min read
Peptide guide
Semaglutide: the complete evidence-based guide
Semaglutide is the first widely adopted GLP-1 receptor agonist for obesity and type-2 diabetes. Here's how it works, what the trials show, and who it fits.
April 20, 2026·7 min read
Comparison
Semaglutide vs tirzepatide: the real head-to-head comparison
Semaglutide vs tirzepatide: a direct head-to-head trial settled the efficacy question. Tirzepatide won on weight loss. Here's what else the evidence actually shows.
April 20, 2026·8 min read
Peptide guide
TB-500 (thymosin beta-4): mechanism and protocol guide
TB-500 is the synthetic thymosin beta-4 fragment used in tissue-repair research. Here's the actin-binding mechanism, the preclinical evidence, and typical protocols.
April 20, 2026·7 min read
Peptide guide
Tesamorelin: the FDA-approved GHRH analogue guide
Tesamorelin is a stabilised GHRH analogue with FDA approval for HIV-associated lipodystrophy. Here's the mechanism, the dosing, and why it's different from CJC-1295.
April 20, 2026·6 min read
Peptide guide
Tirzepatide: the complete evidence-based guide
Tirzepatide is the first dual GIP/GLP-1 receptor agonist. Phase 3 trials show 22.5% mean weight loss at 72 weeks. Here's the full breakdown.
April 20, 2026·6 min read